The clinical pharmacology of a hepatoma-specific alkylating agent.
D000328:Adult; D000477:Alkylating Agents / Q000097:blood / Q000378:metabolism*; D000588:Amines / Q000378:metabolism; D000818:Animals; D001391:Azo Compounds / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D001853:Bone Marrow / Q000201:enzymology; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002648:Child; D005260:Female; D006207:Half-Life; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000378:metabolism; D051381:Rats; D013154:Spleen / Q000201:enzymology; D013997:Time Factors; D062367:ortho-Aminobenzoates / Q000097:blood / Q000378:metabolism
D000477:Alkylating Agents; D000588:Amines; D001391:Azo Compounds; D062367:ortho-Aminobenzoates; D010088:Oxidoreductases